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Abstract
Near infrared spectroscopy (NIRS) has been used to evaluate regional cerebral tissue oxygen saturation  (ScO2) during the 
last decades. Perioperative management algorithms advocate to maintain  ScO2, by maintaining or increasing cardiac output 
(CO), e.g. with fluid infusion. We hypothesized that  ScO2 would increase in responders to a standardized fluid challenge (FC) 
and that the relative changes in CO and  ScO2 would correlate. This study is a retrospective substudy of the FLuid Respon-
siveness Prediction Using Extra Systoles (FLEX) trial. In the FLEX trial, patients were administered two standardized FCs 
(5 mL/kg ideal body weight each) during cardiac surgery. NIRS monitoring was used during the intraoperative period and 
CO was monitored continuously. Patients were considered responders if stroke volume increased more than 10% following 
FC. Datasets from 29 non-responders and 27 responders to FC were available for analysis. Relative changes of  ScO2 did not 
change significantly in non-responders (mean difference − 0.3% ± 2.3%, p = 0.534) or in fluid responders (mean difference 
1.6% ± 4.6%, p = 0.088). Relative changes in CO and  ScO2 correlated significantly, p = 0.027. Increasing CO by fluid did 
not change cerebral oxygenation. Despite this, relative changes in CO correlated to relative changes in  ScO2. However, the 
clinical impact of the present observations is unclear, and the results must be interpreted with caution.
Trial registration: http://Clini calTr ial.gov identifier for main study (FLuid Responsiveness Prediction Using Extra Systo-
les—FLEX): NCT03002129.
Keywords Cardiac anaesthesia · Monitoring · Near infrared spectroscopy · Cerebral oximetry · Fluid challenge · Cardiac 
output
1 Introduction
In the last decades, near infrared spectroscopy (NIRS) moni-
toring has gained interest as a tool to monitor cerebral oxy-
genation and perfusion during cardiac surgery in an attempt 
to minimize cerebral complications [1–4]. NIRS works by 
measuring cerebral tissue oxygen saturation  (ScO2) and 
reflects an approximately 25/75 arterial/venous saturation 
ratio, depending on the device used [5, 6]. Numerous inter-
vention algorithms to mitigate and reverse cerebral desatura-
tion have been published, of which the one published in 2007 
appears widely adopted [7]. Application of this hierarchical 
algorithm has lowered the time with cerebral desaturation 
measured by NIRS [8–11]. However, it is not clear which 
part(s) of the algorithm is the successful one to convert an 
ongoing desaturation. Part of the intervention algorithm is to 
increase cardiac output (CO) if cerebral desaturation occurs 
as indicated by decreased  ScO2. However, this intervention 
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per se has been tested primarily in non-cardiac surgery with 
diverging findings [12–15].
The aim of this study was to elucidate the difference in 
 ScO2 after versus before a standardized 5 mL/kg ideal body 
weight fluid challenge (FC). Furthermore, we studied the 
association between relative changes in ScO2 and CO dur-
ing a standardized FC in hemodynamic responders and non-
responders to a FC in adult patients undergoing cardiac sur-
gery. Responders were defined as patients with an increase 
in stroke volume, SV > 10% following FC.
We hypothesized that in responders  ScO2 would increase, 
as opposed to non-responders. Furthermore, we hypothe-
sized that relative changes of CO and  ScO2 would correlate.
2  Methods
2.1  Study setting
This study is a retrospective substudy of the FLuid Respon-
siveness Prediction Using Extra Systoles (FLEX) trial [16]. 
The trial was conducted at the University Medical Center 
Groningen (UMCG), The Netherlands between January 
2017 and June 2017. The FLEX study was approved by the 
local Institutional Review Board (METc UMCG number 
2016.449, ABR number NL58966.042.16) and registered 
at http://Clini calTr ial.gov (NCT03002129).
2.2  Participants
All participants in the FLEX trial were older than 18 years 
of age and scheduled for elective coronary artery bypass 
grafting with no additional procedures, with or without the 
use of cardiopulmonary bypass (CPB). Exclusion criteria 
were preoperative left ventricular ejection fraction < 35%, 
kidney function requiring haemodialysis, and heart rhythm 
disturbances such as atrial fibrillation or frequent extra 
systoles. Written informed consent was obtained from all 
patients included.
2.3  Study protocol
The study protocol and the primary results from the FLEX 
trial have been previously published [16]. In short, all 
patients received a standardized FC (5 mL/kg ideal body 
weight of lactated Ringer; Baxter, Utrecht, The Netherlands) 
at two time points during surgery. FC1: after induction of 
anaesthesia and placement of the central venous catheter and 
before surgical incision. FC2: during preparation of the left 
internal mammarian artery. Changes to all other infusion 
rates as well as vasoactive interventions were avoided dur-
ing the infusion periods, which were approximately 5 min.
2.4  Data acquisition
2.4.1  Cerebral oximetry
NIRS monitoring was obtained with self-adhesive sensors 
(Medtronic/Covidien INVOS Cerebral/Somatic Oximetry 
Adult Sensors—Medtronic, Minneapolis, USA) placed 
bilaterally on the patient’s forehead before induction of 
anaesthesia. The sensors were connected to a Covidien/
Medtronic INVOS 5100c Cerebral/Somatic Oxime-
ter monitor (Medtronic, Minneapolis, USA). Data was 
recorded in the electronic hospital patient data manage-
ment system developed to sample data during cardiac 
surgery (CAROLA, RIVM Centrum Extreme Veiligheid, 
Bilthoven, The Netherlands) with  ScO2 baseline marked 
before anaesthesia related preoxygenation and sampled 
every 30 s and no in-unit data storage was used. Data was 
exported to Excel format after surgery.
All variables analysed were mean values of left and 
right channel. In case a patient had only unilateral NIRS 
readings one channel was used for analysis.
2.4.2  Hemodynamic measurements and alignment 
to the NIRS readings
All patients were equipped with FloTrac sensors, which 
were connected to the EV1000 hemodynamic monitor 
(both Edwards Lifesciences, Irvine, USA) for continu-
ous measurement of SV, CO, and mean arterial pressure 
(MAP). The EV1000 monitor sampled data every 20 s 
and all data was later exported to Excel format. FC was 
marked in the monitor system. MAP was also recorded by 
the CAROLA system and therefore MAP time series were 
used to align data for CO from the EV1000 monitor and 
 ScO2 values from the CAROLA system. All values were 
analysed from the last registered value before FC start and 
then for the following period of the FC in 1-min intervals. 
Last extracted value was the first value registered after FC 
was ended.
Not all patients had complete NIRS readings and hemo-
dynamic data, since the use of NIRS was dependent on 
the preference of the anaesthetist. To maximize the out-
put from the available data FC1 and FC2 were pooled for 
analysis.
Haematocrit levels from arterial blood gasses were 
extracted from the CAROLA system as the first and last 
value accessible in the procedure.
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2.5  Outcome
2.5.1  Regional cerebral oximetry
The primary outcome was to evaluate relative changes in 
 ScO2 during two FCs. Furthermore, the absolute difference 
in  ScO2 was evaluated for each individual as well as the 
correlation of  ScO2 and CO.
2.6  Statistical analysis
Statistical analyses were performed using SPSS (IBM Corp. 
Released 2013. IBM SPSS Statistics for Windows, Version 
22.0. Armonk, NY: IBM Corp.).
All analyses were conducted for the whole sample of 
datasets and subsequently stratified for non-responders and 
fluid responders, except for correlation analysis which was 
conducted for the whole sample only.
The normality of data distribution was evaluated by visual 
inspection of quantile–quantile plots. Normally distributed 
data are presented as mean ± standard deviation (SD), oth-
erwise as median and interquartile range (IQR). Normally 
distributed data were compared with paired sample t test for 
difference between different time points. Student’s t-test was 
used to test for difference between groups. Categorical data 
are presented as numbers and percentages and compared 
with Pearson’s Chi square test or Fisher’s exact test. Statisti-
cal significance was assessed at the 5% level.
Correlation was tested with the Pearson correlation 
coefficient.
No sample size calculation was performed since this 
study was a secondary analysis of an already finished trial. 
Statistical power is expressed through the reported confi-
dence intervals.
3  Results
Sixty-one patients were included in the FLEX study. 
Twenty-seven patients had complete sets of hemodynamic 
data and NIRS data at FC1. At FC2, 29 patients had com-
plete datasets. In total, this allowed analysis of 56 complete 
datasets comprising 29 non-responders and 27 fluid respond-
ers datasets from 31 unique patients.
Preoperative characteristics, medication, comorbidity and 
intraoperative data are presented in Table 1 for patients with 
complete datasets at both FC1 and FC2 (n = 25). Tables 1A 
and 1B (Appendix S1) illustrate that there was no difference 
in any of the pre-operative variables for non-responders vs. 
fluid responders at either FC1 or FC2.
Table 2 illustrates the difference in absolute values and rela-
tive changes for CO and  ScO2 before and after FC. In general, 
CO and MAP increased significantly for both non-responders 
and responders. CO before FC for fluid responders were mark-
edly lower than the corresponding CO for non-responders 
(3.3 ± 0.8 L/min vs. 4.5 ± 1.4 L/min, p < 0.001).
The differences in relative changes in  ScO2 for fluid 
responders (mean difference 1.6% and 95% CI − 0.3; 3.4, 
p = 0.088) and non-responders (mean difference − 0.3% and 
95% CI − 1.2; 0.6, p = 0.534) was not significant. The  ScO2 
difference in absolute values before and after FC was not 
significant for either fluid responders (66 ± 7% vs. 67 ± 6%, 
p = 0.084) or non-responders (66 ± 6% vs. 66 ± 7%, p = 0.555).
CO and  ScO2 obtained at the end of FC as relative change 
to the value before FC are plotted in Fig. 1 and the correlation 
coefficient was 0.295, p = 0.027. In Fig. 2 (fluid non-respond-
ers) and Fig. 3 (fluid responders) the relative changes minute 
by minute during the FC are presented, showing that the cor-
relations are driven by the fluid responders.  
Table 1  Patient characteristics
Values are presented as means with ± standard deviation and fre-
quency with (percentage)
FC fluid challenge, BMI body mass index, ACE angiotensin-convert-
ing-enzyme, ASA American Society of Anaesthesiologist classifica-
tion of physical health, COPD chronic obstructive pulmonary disease, 
Hct haematocrit, OPCABG off-pump coronary artery bypass grafting
Patients with complete data at both FC1 + FC2 (n = 25)
Preoperative characteristics
 Age 67.2 ± 10.6
 BMI 28.2 ± 3.9
 Male gender 22 (88%)
Medication
 Beta blocker 19 (76%)
 Calcium channel blocker 7 (28%)










 Infused fluid at FC (mL) 380 ± 50
 Hct start procedure (%) 38 ± 4
 Hct end procedure (%) 33 ± 5
 Hct difference start–end (%) 5 ± 3
 OPCABG (opposite to on pump) 23 (92%)
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4  Discussion
The main finding of the present study was that the  ScO2 did 
not change for both responders and non-responders of a FC 
during cardiac surgery. Despite this, relative changes of CO 
and  ScO2 correlated significantly.
It is complicated to compare the results of the present 
study to the existing literature head-to-head, due to hetero-
geneity in study designs and settings. Our study is methodo-
logically different from many other studies investigating the 
hemodynamic effects of a FC, since we had pre-specified 
time points for the FCs, which we integrated with stand-
ard clinical care of our patients (i.e. those accommodating 
the inclusion criteria). Across fluid responsiveness studies, 
around 50% of included patients are non-responders to a 
FC [17]. This is similar in our study, despite the difference 
in study design. While a different design could have altered 
the study findings, we find it difficult to speculate what dif-
ferences to expect.
In the most frequently used intervention algorithm [7] 
the suggestion to increase  ScO2 through an increase in 
CO is based on two small studies: one study reporting that 
 ScO2 decreased in patients with normotensive acute heart 
failure and improved when heart failure was treated [12], 
and one study showing that  ScO2 decreased during exer-
cise in patients with left ventricular dysfunction [13]. In 
the CPB setting it has previously been described in a study 
testing the intervention algorithm, that increasing pump 
blood flow was the most successful instrument to mini-
mize cerebral desaturation measured with NIRS [8] even 
Table 2  Analysed variables 
before fluid challenge and 
immediately after fluid 
challenge
Values are presented as means with ± standard deviation
FC fluid challenge, CO cardiac output, CI cardiac index, SV stroke volume, SVI stroke volume index, MAP 
mean arterial pressure, HR heart rate, ScO2 cerebral oxygen saturation, bpm beats per minute
a Index value: before FC = index 100
Before After Mean difference 95% CI p
All patients: FC1 + FC2. 56 datasets
 ScO2 (%) 66 ± 6 66 ± 6 0 ± 2 − 0.2; 1.0 0.234
 ScO2 rel. (%) 100a 100.6 ± 3.7 0.6 ± 3.7 − 0.4; 1.6 0.217
 CO (L/min) 3.9 ± 1.3 4.4 ± 1.3 0.5 ± 0.5 0.3; 0.6 < 0.001
 CO rel. (%) 100a 112.7 ± 15.3 12.7 ± 15.3 8.3; 15.9 < 0.001
 CI (L/min/m2) 2.0 ± 0.6 2.2 ± 0.6 0.2 ± 0.2 0.1; 0.3 < 0.001
 SV (mL) 75 ± 23 84 ± 23 9 ± 8.5 7; 11 < 0.001
 SVI (mL/m2) 38 ± 11 42 ± 11 5 ± 4 3; 6 < 0.001
 MAP (mmHg) 73 ± 13 77 ± 13 4 ± 7 2; 6 < 0.001
 HR (bpm) 52 ± 8 51 ± 8 − 1 ± 3 0.0; − 1.5 0.049
Non-responders: FC1 + FC2. 29 datasets
 ScO2 (%) 66 ± 6 66 ± 7 0 ± 2 − 0.7; 0.4 0.555
 ScO2 rel. (%) 100a 99.7 ± 2.3 − 0.3 ± 2.3 − 1.2; 0.6 0.534
 CO (L/min) 4.5 ± 1.43 4.7 ± 1.5 0.2 ± 0.4 0.0; 0.3 0.015
 CO rel. (%) 100a 104.1 ± 10.5 4.1 ± 10.5 0.1; 8.1 0.044
 CI (L/min/m2) 2.3 ± 0.6 2.4 ± 0.7 0.1 ± 0.2 0.1; 0.2 0.012
 SV (mL) 84 ± 26 88 ± 28 4 ± 6 1; 6 0.002
 SVI (mL/m2) 43 ± 11 45 ± 12 2 ± 4 1; 3 0.004
 MAP (mmHg) 76 ± 12 79 ± 14 3 ± 6 1; 5 0.016
 HR (bpm) 54 ± 9 53 ± 9 1 ± 3 − 1; 1 0.588
Responders: FC1 + FC2. 27 datasets
 ScO2 (%) 66 ± 7 67 ± 6 1 ± 3 − 0.1; 2.0 0.084
 ScO2 rel. (%) 100a 101.6 ± 4.6 1.6 ± 4.6 − 0.3; 3.4 0.088
 CO (L/min) 3.3 ± 0.8 4.0 ± 1.0 0.7 ± 0.4 0.5; 0.9 < 0.001
 CO rel. (%) 100a 122 ± 14.2 22.0 ± 14.0 16.0; 28.0 < 0.001
 CI (L/min/m2) 1.6 ± 0.4 2.0 ± 0.5 0.4 ± 0.2 0.2; 0.4 < 0.001
 SV (mL) 66 ± 15 80 ± 17 15 ± 7 12; 18 < 0.001
 SVI (mL/m2) 32 ± 8 39 ± 9 7 ± 3 6; 9 < 0.001
 MAP (mmHg) 75 ± 13 80 ± 13 5 ± 8 2; 8 0.005
 HR (bpm) 51 ± 8 50 ± 8 1 ± 3 0; 2 0.027
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though different pump flow levels have been shown not to 
affect the cerebral blood flow during CPB [18]. Further-
more, a recently published physiological proof of concept 
study showed that an increase in CPB pump flow lead to an 
increase in MAP and an increase in  ScO2 whereas admin-
istration of phenylephrine and vasopressin increased MAP 
but decreased  ScO2 [19]. In a randomised trial with two 
distinct levels of MAP during CPB with fixed pump flow 
the high MAP target group had lower NIRS values com-
pared to the low MAP target group [20]. Conversely, in the 
off-pump setting, a study investigating the relationship of 
central venous oxygen saturation and  ScO2 during a FC 
after cardiac surgery found no differences in  ScO2 before 
and after FC for either fluid responders or non-responders 
[14]. However, central venous oxygen saturation was sig-
nificantly higher for responders after FC whereas it did 
not change in non-responders. Unfortunately, we did not 
measure central venous oxygen saturation in the present 
study at relevant time points.
It was previously described that even though the patient 
remains within the MAP limits of cerebral autoregulation, 
the changes in CO can affect  ScO2 [21]. The MAP levels 
for the patients in the present study also stayed within the 
assumed limits of cerebral autoregulation, as presented in 
Table 2, both before and after FC for both fluid respond-
ers and non-responders, although it has been shown that 
the limits of autoregulation may differ markedly between 
individuals [22–24]. With regard to cerebral autoregula-
tion it was previously described that the lower limit of 
autoregulation seems to vary when the central blood vol-
ume or CO were lowered [25–28], which needs to be taken 
into account when evaluating the effect of a FC. In cases 
where CO is distinctively low, a FC may generate more 
pronounced responses in cerebral blood flow and subse-
quently in  ScO2. Another factor to keep in mind when 
interpreting the effect of a FC on  ScO2 is the possible 
“contamination” of the signal by extracranial perfusion 
[29], potentially causing a false increase in the NIRS read-
ings. No matter the underlying explanation, we believe the 
resulting effect of a FC on  ScO2 can be evaluated per se, 
which is further emphasized by the Figs. 2 and 3 illustrat-
ing an immediate response minute by minute during the 
FC. We chose to report both relative and absolute values 
of  ScO2 since baseline values can vary markedly between 
individuals [30]. To facilitate the clinical interpretation, 
we kept relative changes as the primary outcome since it 
is an optimal way to reflect results in the individual patient 
due to individual differences in baseline values.
Fig. 1  Scatterplot illustrating  ScO2 and CO at the end of fluid chal-
lenge expressed as the relative change to the value before fluid chal-
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Minutes into fluid challenge
Correlaon of relave changes for ScO2 and CO from baseline
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correlaon coefficient p
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CO relave change (r. axis)
Fig. 2  Graph illustrating the relative changes and the correlation 
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CO relave change (r. axis)
Fig. 3  Graph illustrating the relative changes and the correlation 
between  ScO2 and CO minute by minute into the fluid challenge for 
fluid challenge responders
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The relative increase in  ScO2 was on average 2% for 
fluid responders, in absolute  ScO2 values this increase was 
1%, but both turned out statistically non-significant.
Despite the statistically significant observations of cor-
relation between CO and  ScO2, one must keep in mind 
that the clinical relevance of a difference as found in the 
present study is uncertain. It is very difficult to define a 
clinically relevant threshold of  ScO2 levels and the defini-
tion of cerebral desaturation assessed with NIRS is vague 
[31]. Patient characteristics, or intraoperative data includ-
ing haematocrit, can possibly influence the  ScO2 readings 
[32, 33]. We observed a comparable haemodilution during 
surgery for fluid responders and non-responders—obvi-
ously due to the administered fluid in each FC. There-
fore, when interpreting the results of the present study, 
the effect on  ScO2 of a FC may be less than expected, 
since the tool to increase CO in this study also generates 
haemodilution. Therefore, other methods to increase CO 
without causing haemodilution (e.g. blood transfusions) 
might show a more pronounced increase in  ScO2.
The present study has several limitations. Since this 
study is a substudy and a retrospective analysis of a clini-
cal trial, no sample size calculation was performed. The 
main result was not significant and it may be caused by a 
type 2 error. As this study is a retrospective analysis, it 
was not designed to test the effect of a FC with a higher 
volume, which may have caused a more distinct response 
in  ScO2, since hemodynamic variables demonstrated signs 
of hypovolaemia before—and for some patients after—
FC. Only half of the possible data sets were complete and 
suitable for analysis and therefore no imputation method 
was used. The NIRS readings can possibly differ between 
different manufactures, as previously reported [29]. There-
fore, the results may be interpreted with caution when 
comparing it with that of other studies using different 
NIRS devices.
In conclusion, the findings of the present study sup-
port the current guidelines to increase CO when it comes 
to maintain  ScO2 values, but only in conditions where 
patients are fluid responsive. The clinical impact of small 
deviations in  ScO2 on patient outcome is barely described 
and this study is only indicative that  ScO2 may be aug-
mented through fluid-induced increases in CO due to the 
demonstrated correlation between relative changes in  ScO2 
and CO.
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